Federal Circuit backs Boston Scientific in stent clash
02-10-2017
Boston Scientific and Abbott caught up in patent claim
14-03-2017
Jan-Otto / iStockphoto.com
California-based FlexStent accused healthcare company Abbott Laboratories of infringing a stent patent earlier this week, with the filing of a lawsuit at the US District Court for the Central District of California.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Abbott Laboratories, FlexStent, medical devices, patent infringement, coronary stents, medical devices
